(-)-demecolcine increases expression ISO RGD:733428 6480464 Demecolcine results in increased expression of FBN2 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:733428 6480464 epigallocatechin gallate results in decreased expression of FBN2 mRNA CTD PMID:20706672 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:733428 6480464 o, p'-DDT results in increased expression of FBN2 mRNA CTD PMID:18204070 1,2-dichloroethane decreases expression ISO RGD:733429 6480464 ethylene dichloride results in decreased expression of FBN2 mRNA CTD PMID:28960355 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FBN2 mRNA CTD PMID:30723492 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of FBN2 mRNA CTD PMID:15834898 , PMID:17557909 17beta-estradiol affects expression ISO RGD:733428 6480464 Estradiol affects the expression of FBN2 mRNA CTD PMID:22574217 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:733428 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733429 6480464 Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FBN2 mRNA] CTD PMID:16054899 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FBN2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733428 6480464 Tetrachlorodibenzodioxin results in increased expression of FBN2 mRNA CTD PMID:21998131 2,4,6-tribromophenol increases expression ISO RGD:733428 6480464 2 more ... CTD PMID:31675489 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:32119087 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:733428 6480464 tetrabromobisphenol A results in increased expression of FBN2 protein CTD PMID:31675489 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733429 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FBN2 mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FBN2 mRNA] CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733428 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FBN2 mRNA more ... CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:733429 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FBN2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:733429 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of FBN2 gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases methylation ISO RGD:733428 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of FBN2 gene CTD PMID:31601247 4,4'-sulfonyldiphenol multiple interactions ISO RGD:733429 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of FBN2 mRNA CTD PMID:30951980 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FBN2 mRNA CTD PMID:22504374 , PMID:24780913 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:19480007 acrolein multiple interactions ISO RGD:733428 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FBN2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FBN2 mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of FBN2 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:733429 6480464 Acrylamide results in decreased expression of FBN2 mRNA CTD PMID:30807115 aflatoxin B1 affects expression ISO RGD:733428 6480464 Aflatoxin B1 affects the expression of FBN2 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:733428 6480464 Aflatoxin B1 results in increased expression of FBN2 mRNA CTD PMID:21641981 , PMID:32234424 Aflatoxin B2 alpha increases methylation ISO RGD:733428 6480464 aflatoxin B2 results in increased methylation of FBN2 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:733428 6480464 Tretinoin results in decreased expression of FBN2 mRNA, Tretinoin results in decreased expression of FBN2 protein CTD PMID:15498508 more ... all-trans-retinoic acid multiple interactions ISO RGD:733429 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of FBN2 mRNA more ... CTD PMID:30951980 all-trans-retinoic acid multiple interactions ISO RGD:733428 6480464 SMAD3 protein inhibits the reaction [Tretinoin results in decreased expression of FBN2], TGFB3 protein inhibits the reaction [Tretinoin results in decreased expression of FBN2] CTD PMID:24374174 alpha-pinene multiple interactions ISO RGD:733428 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FBN2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FBN2 mRNA CTD PMID:32699268 aristolochic acid A decreases expression ISO RGD:733428 6480464 aristolochic acid I results in decreased expression of FBN2 mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO RGD:733428 6480464 arsenite results in decreased expression of FBN2 mRNA CTD PMID:23974009 arsenite(3-) multiple interactions ISO RGD:733428 6480464 arsenite inhibits the reaction [G3BP1 protein binds to FBN2 mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO RGD:733428 6480464 Arsenic Trioxide results in decreased expression of FBN2 protein CTD PMID:15894607 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of FBN2 gene CTD PMID:28931070 avobenzone increases expression ISO RGD:733428 6480464 avobenzone results in increased expression of FBN2 mRNA CTD PMID:31016361 benzo[a]pyrene decreases methylation ISO RGD:733428 6480464 Benzo(a)pyrene results in decreased methylation of FBN2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:733428 6480464 Benzo(a)pyrene results in increased expression of FBN2 mRNA CTD PMID:32234424 beta-naphthoflavone decreases expression ISO RGD:733428 6480464 beta-Naphthoflavone results in decreased expression of FBN2 mRNA CTD PMID:32858204 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FBN2 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:733428 6480464 bisphenol A results in increased methylation of FBN2 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:733428 6480464 bisphenol A results in decreased expression of FBN2 protein CTD PMID:31675489 bisphenol A multiple interactions ISO RGD:733429 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of FBN2 mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FBN2 gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:733428 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FBN2 mRNA CTD PMID:28628672 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in decreased methylation of FBN2 gene, [bisphenol A co-treated with Genistein] results in increased methylation of FBN2 gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:733429 6480464 bisphenol A results in increased expression of FBN2 mRNA CTD PMID:25594700 , PMID:30951980 Bisphenol B increases expression ISO RGD:733428 6480464 bisphenol B results in increased expression of FBN2 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:733428 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FBN2 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:733429 6480464 bisphenol F results in increased expression of FBN2 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:733429 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of FBN2 mRNA CTD PMID:30951980 bleomycin A5 decreases expression ISO RGD:733428 6480464 bleomycetin results in decreased expression of FBN2 mRNA CTD PMID:21040473 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of FBN2 mRNA CTD PMID:32479839 buta-1,3-diene decreases expression ISO RGD:733429 6480464 1, 3-butadiene results in decreased expression of FBN2 mRNA CTD PMID:29038090 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of FBN2 mRNA CTD PMID:19167457 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of FBN2 promoter CTD PMID:22457795 chlorogenic acid decreases expression ISO RGD:733428 6480464 Chlorogenic Acid results in decreased expression of FBN2 mRNA CTD PMID:20706672 choline multiple interactions ISO RGD:733429 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FBN2 mRNA CTD PMID:20938992 cisplatin decreases expression ISO RGD:733428 6480464 Cisplatin results in decreased expression of FBN2 mRNA CTD PMID:27594783 cobalt dichloride decreases expression ISO RGD:733428 6480464 cobaltous chloride results in decreased expression of FBN2 mRNA CTD PMID:19320972 cobalt dichloride decreases secretion ISO RGD:733428 6480464 cobaltous chloride results in decreased secretion of FBN2 protein CTD PMID:22079246 copper atom multiple interactions ISO RGD:733428 6480464 [NSC 689534 binds to Copper] which results in increased expression of FBN2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:733428 6480464 [NSC 689534 binds to Copper] which results in increased expression of FBN2 mRNA CTD PMID:20971185 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of FBN2 mRNA CTD PMID:15755911 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of FBN2 mRNA CTD PMID:26577399 cyproconazole increases expression ISO RGD:733429 6480464 cyproconazole results in increased expression of FBN2 mRNA CTD PMID:22045034 decabromodiphenyl ether increases expression ISO RGD:733428 6480464 decabromobiphenyl ether results in increased expression of FBN2 protein CTD PMID:31675489 dexamethasone multiple interactions ISO RGD:733429 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FBN2 mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FBN2 mRNA] CTD PMID:16054899 dexamethasone multiple interactions ISO RGD:733428 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FBN2 mRNA more ... CTD PMID:28628672 dexamethasone increases expression ISO RGD:733428 6480464 Dexamethasone results in increased expression of FBN2 mRNA CTD PMID:25047013 diarsenic trioxide decreases expression ISO RGD:733428 6480464 Arsenic Trioxide results in decreased expression of FBN2 protein CTD PMID:15894607 dibutyl phthalate increases expression ISO RGD:733429 6480464 Dibutyl Phthalate results in increased expression of FBN2 mRNA CTD PMID:17361019 , PMID:21266533 dioxygen multiple interactions ISO RGD:733428 6480464 Oxygen inhibits the reaction [darinaparsin results in increased expression of FBN2 mRNA] CTD PMID:22535156 dorsomorphin multiple interactions ISO RGD:733428 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:733428 6480464 Doxorubicin results in increased expression of FBN2 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FBN2 mRNA CTD PMID:29391264 entinostat decreases expression ISO RGD:733428 6480464 entinostat results in decreased expression of FBN2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:733428 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBN2 mRNA CTD PMID:27188386 folic acid multiple interactions ISO RGD:733429 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FBN2 mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:733429 6480464 Folic Acid results in decreased expression of FBN2 mRNA CTD PMID:25629700 genistein decreases expression ISO RGD:733428 6480464 Genistein results in decreased expression of FBN2 mRNA CTD PMID:20706672 genistein increases expression ISO RGD:733429 6480464 Genistein results in increased expression of FBN2 mRNA CTD PMID:32186404 genistein multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in decreased methylation of FBN2 gene, [bisphenol A co-treated with Genistein] results in increased methylation of FBN2 gene CTD PMID:28505145 genistein increases expression ISO RGD:733428 6480464 Genistein results in increased expression of FBN2 mRNA CTD PMID:26865667 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of FBN2 mRNA CTD PMID:33387578 indometacin multiple interactions ISO RGD:733428 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FBN2 mRNA more ... CTD PMID:28628672 kojic acid increases expression ISO RGD:733428 6480464 kojic acid results in increased expression of FBN2 mRNA CTD PMID:16595896 L-methionine multiple interactions ISO RGD:733429 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FBN2 mRNA CTD PMID:20938992 methimazole increases expression EXP 6480464 Methimazole results in increased expression of FBN2 mRNA CTD PMID:22504374 methylmercury chloride increases expression ISO RGD:733428 6480464 methylmercuric chloride results in increased expression of FBN2 mRNA CTD PMID:28001369 methylmercury chloride decreases expression ISO RGD:733428 6480464 methylmercuric chloride results in decreased expression of FBN2 mRNA CTD PMID:34089799 miconazole increases expression ISO RGD:733429 6480464 Miconazole results in increased expression of FBN2 mRNA CTD PMID:27462272 monosodium L-glutamate increases expression ISO RGD:733429 6480464 Sodium Glutamate results in increased expression of FBN2 mRNA CTD PMID:22078008 nickel atom increases expression ISO RGD:733428 6480464 Nickel results in increased expression of FBN2 mRNA CTD PMID:25583101 nickel sulfate decreases expression ISO RGD:733428 6480464 nickel sulfate results in decreased expression of FBN2 mRNA CTD PMID:22714537 ochratoxin A multiple interactions ISO RGD:733428 6480464 [ochratoxin A results in increased acetylation of FBN2 promoter] which results in increased expression of FBN2 mRNA CTD PMID:29098329 ochratoxin A increases acetylation ISO RGD:733428 6480464 ochratoxin A results in increased acetylation of FBN2 promoter CTD PMID:29098329 ochratoxin A increases expression ISO RGD:733428 6480464 ochratoxin A results in increased expression of FBN2 mRNA CTD PMID:29098329 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FBN2 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:733428 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FBN2 mRNA more ... CTD PMID:32699268 paracetamol decreases expression ISO RGD:733428 6480464 Acetaminophen results in decreased expression of FBN2 mRNA CTD PMID:22230336 phenylmercury acetate increases expression ISO RGD:733428 6480464 Phenylmercuric Acetate results in increased expression of FBN2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733428 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBN2 mRNA CTD PMID:27188386 potassium chromate increases expression ISO RGD:733428 6480464 potassium chromate(VI) results in increased expression of FBN2 mRNA CTD PMID:22714537 potassium dichromate increases expression ISO RGD:733429 6480464 Potassium Dichromate results in increased expression of FBN2 mRNA CTD PMID:23608068 progesterone increases expression EXP 6480464 Progesterone results in increased expression of FBN2 mRNA CTD PMID:20726854 propanal increases expression ISO RGD:733428 6480464 propionaldehyde results in increased expression of FBN2 mRNA CTD PMID:26079696 puerarin decreases expression ISO RGD:733428 6480464 puerarin results in decreased expression of FBN2 mRNA CTD PMID:20706672 Rosavin decreases expression ISO RGD:733428 6480464 rosavin results in decreased expression of FBN2 mRNA CTD PMID:20706672 SB 431542 multiple interactions ISO RGD:733428 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:733428 6480464 Silicon Dioxide analog results in increased expression of FBN2 mRNA CTD PMID:23806026 sodium arsenite affects expression ISO RGD:733428 6480464 sodium arsenite affects the expression of FBN2 mRNA CTD PMID:29319823 sodium arsenite decreases expression ISO RGD:733429 6480464 sodium arsenite results in decreased expression of FBN2 mRNA CTD PMID:36209798 sodium arsenite increases expression ISO RGD:733428 6480464 sodium arsenite results in increased expression of FBN2 mRNA CTD PMID:34032870 sulforaphane decreases expression ISO RGD:733428 6480464 sulforaphane results in decreased expression of FBN2 mRNA CTD PMID:31838189 tamibarotene decreases expression ISO RGD:733428 6480464 tamibarotene results in decreased expression of FBN2 mRNA CTD PMID:15498508 thapsigargin increases expression ISO RGD:733428 6480464 Thapsigargin results in increased expression of FBN2 mRNA CTD PMID:29453283 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FBN2 mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of FBN2 gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:733428 6480464 trichostatin A results in increased expression of FBN2 mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:733428 6480464 Triclosan results in decreased expression of FBN2 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:733429 6480464 trimellitic anhydride results in increased expression of FBN2 mRNA CTD PMID:19042947 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of FBN2 protein CTD PMID:32519852 valproic acid affects expression ISO RGD:733429 6480464 Valproic Acid affects the expression of FBN2 mRNA CTD PMID:22045034 valproic acid increases expression ISO RGD:733429 6480464 Valproic Acid results in increased expression of FBN2 mRNA CTD PMID:24896083 valproic acid decreases expression ISO RGD:733428 6480464 Valproic Acid results in decreased expression of FBN2 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:733428 6480464 Valproic Acid results in increased expression of FBN2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:733428 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBN2 mRNA CTD PMID:27188386
